Search Results for “New LFCA Test Score Report Free PDF | Valid LFCA Test Questions: Linux Foundation Certified IT Associat 🥅 Search on ⏩ www.pdfvce.com ⏪ for ⇛ LFCA ⇚ to obtain exam materials for free download 🌱LFCA Vce Exam” – Page 22

Treatment of urticarial vasculitis: A systematic review

342	Kolkhir, P., Grakhova, M., Bonnekoh, H., Krause, K., and Maurer, M.+**: Treatment of urticarial vasculitis: a systematic review. J. Allergy Clin. Immunol. 2019: 143; 458-466. IF: TBD (IF 2018: 14.11)

228	Gericke, J., Ohanyan, T., Church, M. K., Maurer, M.+ and Metz, M.: Omalizumab may not inhibit mast cell and basophil activation in vitro. J. Eur. Acad. Dermatol. Venereol. 2015: 29; 1832-1836. IF: 2.82

Evaluation of the Immunogenicity of the Synthetic α-Melanocyte-Stimulating Hormone (α-MSH) Analogue Afamelanotide ([Nle 4 – D -Phe 7 ]-α-MSH, Scenesse ® ) in Erythropoietic Protoporphyria Patients by ELISA Detecting Both Anti-Afamelanotide and Anti-α-MSH Antibodies

203

Lengweiler, S. , Kreim, S. , Barman-Aksozen, J., Maurer, M. and Minder, E.+: Evaluation of the immunogenicity of the α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle 4-D-Phe 7] – α-MSH, scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies. Skin Pharmacol. Physiol. 2015: 28; 103-113. IF: 2.48

o.203

183	Metz, M., Ohanyan, T., Church, M. K., and Maurer, M.+: Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. JAMA Derm. 2014: 150; 288-290. IF: 4.43

39	Orinska, Z., Bulanova, E., Budagian, V., Metz, M., Maurer, M. and Bulfone-Paus, S.+: TLR3-induced activation of mast cells modulates CD8+ T cell-recruitment. Blood 2005: 106; 978-987. IF: 10.13

236	Vadasz, Z., Kessel, A., Hershko, A. Y., Maurer, M. and Toubi, E.+: Seasonal exacerbation of asthma is frequently associated with recurrent episodes of acute urticaria. Int. Arch. Allergy Immunol. 2016: 169; 263-266. IF: 2.72

424.	Sauer, M., Scheffel, J., Frischbutter, S., Kolkhir, P., Xiang, Y.-K., Siebenhaar, F., Altrichter, S., Maurer, M., Metz, M., and Krause, K.⁺: Lower IgA levels in chronic spontaneous urticaria are associated with lower IgE levels and autoimmunity. Front. Immunol. 2021: 12; 657211. IF: 8.79

o.424

Rupatadine in established treatment schemes improves chronic spontaneous urticaria symptoms and patients’ quality of life: a prospective, non-interventional trial

229

Metz, M., Weller, K., Neumeister, C., Izquierdo, I., Bödeker, R. H., Schwantes, U.+, and Maurer, M.:Rupatadine in established treatment schemes improves chronic spontaneous urticaria symptoms and patients’ quality of life: a prospective, non-interventional trial. Dermatol. Ther. 2015: 5; 217-230. IF: 1.26

186	Altrichter, S., Salow, J., Ardelean, E., Church, M. K.+, Werner, A., and Maurer, M.: Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J. Dermatol. Sci. 2014: 75; 88-93. IF: 3.42

o.186

Searching for genetic biomarkers for hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE)

511.

Parsopoulou, F., Loules, G., Zamanakou, M., Csuka, D., Szilagyi, A., Kompoti, M., Porebski, G., Psarros, G., Psarros, F., Magerl, M., Valerieva, A., Staevska, M., Obtulowicz, K., Maurer, M., Speletas, M., Farkas, H., and Germenis, A. E.⁺: Searching for genetic biomarkers for hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE). Front. Allergy 2022: 3; 868185. IF: N/A

o.511

Results